<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><description>让药物创造变得容易！我们致力于成为中国健康产业的传播者、服务者、推动者。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 31 Mar 2021 19:20:24 +0800</pubDate><image><url>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</url><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>总融资额超180亿，总估值近2000亿，一季度医药行业所有融资中均与创新药相关？</title><link>https://mp.weixin.qq.com/s/Hkw4ehWtiF1TVkkGqI1pGw</link><description></description><content:encoded><![CDATA[总融资额超180亿，总估值近2000亿，一季度医药行业所有融资中均与创新药相关？]]></content:encoded><pubDate>Wed, 31 Mar 2021 18:22:19 +0800</pubDate></item><item><title>重磅，新冠疫苗第二针推迟一周后再打</title><link>https://mp.weixin.qq.com/s/3bmbFtQ1WS_9SQt7zQ3HuA</link><description></description><content:encoded><![CDATA[重磅，新冠疫苗第二针推迟一周后再打]]></content:encoded><pubDate>Wed, 31 Mar 2021 18:22:19 +0800</pubDate></item><item><title>知名药企宣布，裁撤员工</title><link>https://mp.weixin.qq.com/s/9xdE4Nyb1K6dvrN_DyaaqA</link><description></description><content:encoded><![CDATA[知名药企宣布，裁撤员工]]></content:encoded><pubDate>Wed, 31 Mar 2021 18:22:19 +0800</pubDate></item><item><title>重磅！69个药品被医保盯上了</title><link>https://mp.weixin.qq.com/s/h1_pPmfxZUUJnKh74rclCQ</link><description></description><content:encoded><![CDATA[重磅！69个药品被医保盯上了]]></content:encoded><pubDate>Wed, 31 Mar 2021 18:22:19 +0800</pubDate></item><item><title>2021太湖湾生命健康未来大会</title><link>https://mp.weixin.qq.com/s/9VJTNG9b7fXB1asvHtPE1w</link><description></description><content:encoded><![CDATA[2021太湖湾生命健康未来大会]]></content:encoded><pubDate>Wed, 31 Mar 2021 18:22:19 +0800</pubDate></item><item><title>CXO龙头康龙化成2020年业绩强劲依旧，临床研究服务增速最高</title><link>https://mp.weixin.qq.com/s/PppsqvqCLUSeSU7O48glvQ</link><description></description><content:encoded><![CDATA[CXO龙头康龙化成2020年业绩强劲依旧，临床研究服务增速最高]]></content:encoded><pubDate>Tue, 30 Mar 2021 15:08:44 +0800</pubDate></item><item><title>生物医药创新“百花齐放”，临床研发快车道在哪里？</title><link>https://mp.weixin.qq.com/s/7HV5ekAdx_vXBNR_ahIvLw</link><description></description><content:encoded><![CDATA[生物医药创新“百花齐放”，临床研发快车道在哪里？]]></content:encoded><pubDate>Tue, 30 Mar 2021 15:08:44 +0800</pubDate></item><item><title>在第五批集采前，这些省已经开始集采了</title><link>https://mp.weixin.qq.com/s/DtntUEPHFaayuXqxSpCo9g</link><description></description><content:encoded><![CDATA[在第五批集采前，这些省已经开始集采了]]></content:encoded><pubDate>Tue, 30 Mar 2021 15:08:44 +0800</pubDate></item><item><title>新冠疫苗的有效性如何？或将迎来“终结者考验”</title><link>https://mp.weixin.qq.com/s/ZHqS8diT7ZMsjyuXSW1O0w</link><description></description><content:encoded><![CDATA[新冠疫苗的有效性如何？或将迎来“终结者考验”]]></content:encoded><pubDate>Tue, 30 Mar 2021 15:08:44 +0800</pubDate></item><item><title>5位专家建言：创新药入院“最后一公里”难题！</title><link>https://mp.weixin.qq.com/s/BjU2DtaAA2iZRFvlKtLBJw</link><description></description><content:encoded><![CDATA[5位专家建言：创新药入院“最后一公里”难题！]]></content:encoded><pubDate>Mon, 29 Mar 2021 15:56:08 +0800</pubDate></item><item><title>首款|靶向BCMA CAR-T细胞疗法获批上市！商业化赛道正式开启</title><link>https://mp.weixin.qq.com/s/TF43C02AjTPWTcEbc6Zv8w</link><description></description><content:encoded><![CDATA[首款|靶向BCMA CAR-T细胞疗法获批上市！商业化赛道正式开启]]></content:encoded><pubDate>Mon, 29 Mar 2021 15:56:08 +0800</pubDate></item><item><title>医保谈判产品，进院难了</title><link>https://mp.weixin.qq.com/s/ilBTtdm3DHfViB3fiyN8Sw</link><description></description><content:encoded><![CDATA[医保谈判产品，进院难了]]></content:encoded><pubDate>Mon, 29 Mar 2021 15:56:08 +0800</pubDate></item><item><title>同写意第116期丨2021中国·扬州生物医药论坛（NEW））</title><link>https://mp.weixin.qq.com/s/Dl8VeVicsLjql6WPYQdNMA</link><description></description><content:encoded><![CDATA[同写意第116期丨2021中国·扬州生物医药论坛（NEW））]]></content:encoded><pubDate>Mon, 29 Mar 2021 15:56:08 +0800</pubDate></item><item><title>【药咖君】中国首个RET抑制剂获批上市！PD-1适应症抢夺战进行中，恒瑞、基石药业…</title><link>https://mp.weixin.qq.com/s/AR7WqqI9DXzyzcX5Hu2WHQ</link><description></description><content:encoded><![CDATA[【药咖君】中国首个RET抑制剂获批上市！PD-1适应症抢夺战进行中，恒瑞、基石药业…]]></content:encoded><pubDate>Sun, 28 Mar 2021 10:18:45 +0800</pubDate></item><item><title>同写意第115期丨抗体药先进工艺与产业化发展峰会（NEW）</title><link>https://mp.weixin.qq.com/s/MBMIAIsmDMmXiq070jXhbg</link><description></description><content:encoded><![CDATA[同写意第115期丨抗体药先进工艺与产业化发展峰会（NEW）]]></content:encoded><pubDate>Sun, 28 Mar 2021 10:18:45 +0800</pubDate></item><item><title>PROTAC的昨天、今天和明天</title><link>https://mp.weixin.qq.com/s/Zn4c2BNdYFhWGiT2hhDEuA</link><description></description><content:encoded><![CDATA[PROTAC的昨天、今天和明天]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:02:15 +0800</pubDate></item><item><title>17家企业公布年报：3成净利涨幅超100%，净利最高达600%，仅4家药企同比下降</title><link>https://mp.weixin.qq.com/s/aQXrRA1ciNYKR2h9enZZ5g</link><description></description><content:encoded><![CDATA[17家企业公布年报：3成净利涨幅超100%，净利最高达600%，仅4家药企同比下降]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:01:44 +0800</pubDate></item><item><title>全方位无死角降维打击！药企合规管理再收紧</title><link>https://mp.weixin.qq.com/s/yJ-QarWGfTaDU98EFKm26A</link><description></description><content:encoded><![CDATA[全方位无死角降维打击！药企合规管理再收紧]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:01:44 +0800</pubDate></item><item><title>三甲副院长落马，多名药企负责人涉案</title><link>https://mp.weixin.qq.com/s/Q59e_97As0TxT0NWnYQ-xA</link><description></description><content:encoded><![CDATA[三甲副院长落马，多名药企负责人涉案]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:01:44 +0800</pubDate></item><item><title>2021生物制品注册法规及M4申报案例</title><link>https://mp.weixin.qq.com/s/96fZyJys5h_AtoQDoKgvOg</link><description></description><content:encoded><![CDATA[2021生物制品注册法规及M4申报案例]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:01:44 +0800</pubDate></item></channel></rss>